Health Canada has authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the ...

Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up.

Shares of Novavax Inc. NVAX slid 2.86% to $12.56 Wednesday, on what proved to be an all-around dismal trading session for the ...

Buying $1000 In NVAX: If an investor had bought $1000 of NVAX stock 5 years ago, it would be worth $2,000.00 today based on a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

However, with COVID-19 stubbornly sticking around, investors should focus on an obscure, up-and-coming COVID-19 vaccine maker called Novavax. Novavax (NVAX) is a biotech company that develops ...

Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide Novavax's updated vaccine is the only protein-based option available in the U.S. this fall ...

Novavax, Inc. (NVAX) announced Friday that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to ...

Novavax received emergency use authorization for an updated vaccine. The biotech is benefiting from a partnership with Sanofi. However, its prospects remain unpredictable. Though we are no longer ...

That's the case with Johnson & Johnson's vaccine. However, Novavax has remained a notable player in this field. The biotech recently said that its updated vaccine received EUA from the U.S. Food ...